InvestSMART

Regis Healthcare Limited (ASX:REG)

ALERT: Price-sensitive ASX Announcement for REG
Current share price for REG : $6.160 -0.38 (-5.81%)+
Announcement
Release
29 Apr 2026 8:39AM
Price at Release
$6.540
Full Release
download
Summary
Regis Healthcare Limited announced the appointment of Andrew Kinkade as the new Managing Director and Chief Executive Officer, succeeding Dr. Linda Mellors. Andrew Kinkade brings over 20 years of experience in aged care, healthcare, private equity, and investment banking, most recently serving as the Managing Director of Bupa Villages & Aged Care. His leadership is recognized for delivering operational and cultural transformation, as well as significant growth and value creation. The appointment process included an independent search conducted by Korn Ferry. Andrew Kinkade will officially join Regis on 20 July 2026. His remuneration package includes a total fixed remuneration of $900,000 per annum along with the potential for short and long-term incentives. The Regis Board expressed confidence in Kinkade's ability to lead the company and contribute to the growth and strategic initiatives within the aged care sector.
Key Points
  • Andrew Kinkade appointed as Managing Director & CEO of Regis Healthcare.
  • Andrew will succeed Dr. Linda Mellors, whose resignation was announced on 22 December 2025.
  • Andrew has over 20 years of experience in related sectors.
  • His previous role was Managing Director at Bupa Villages & Aged Care.
  • He is recognized for operational and cultural transformation and value creation.
  • The appointment was facilitated by Korn Ferry through an independent search.
  • Andrew's start date is 20 July 2026.
  • His remuneration includes a $900,000 salary, with additional incentives based on performance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.